Find a TenderAwarded

Published 30 Jan 2024, 15:04 GMT

Official UK procurement notice

Contract for ENCORAFENIB (BRAFTOVI) 75mg Capsules

Official notice

Authority: Northern Health and Social Care Trust (Central government)

GoodsNegotiated without publication of a contract notice

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£162,120published contract · exc. VAT

Awarded 1 Jan 2024

Awarded to PIERRE FABRE LIMITED

What is being bought

Published requirement description

Contract for supply of ENCORAFENIB (BRAFTOVI) 75mg Capsules

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1Contract for supply of ENCORAFENIB (BRAFTOVI) 75mg Capsules for up to a maximum of 36…

Contract for supply of ENCORAFENIB (BRAFTOVI) 75mg Capsules for up to a maximum of 36 months

Delivery: Northern Ireland

33600000 Pharmaceutical products

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price

Procedure terms & legal framework

From the official record

Procedure method: Negotiated without publication of a contract notice
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 30 Jan 2024, 15:04 GMT
Last source update: 30 Jan 2024, 15:04 GMT
Authority reference: DAC85/0124PM
FTS notice number: 2024/S 000-003083
Classification (CPV): Pharmaceutical products
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-0435bd Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
The Northern Trust requires the purchase of Encorafenib 75mg capsules which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £162,1201 contract exc. VAT

Contracts signed 1latest 1 Jan 2024

Awarded to	Value	Date	Status
PIERRE FABRE LIMITED	£162,120 †	—	Awarded

Contracts

Contract 003083-2024-DAC85/0124PM-1 · PIERRE FABRE LIMITED
Signed
1 Jan 2024
Value
£162,120
Status
active

Contracting authority & participating public bodies

Northern Health and Social Care Trust

Contracting authorityCentral GovernmentBody governed by public lawHealth Bush Road, Antrim, Northern Ireland, BT41 2RLContact email, phone

Bidders & participating suppliers

1 commercial party on the notice

Pierre Fabre Ltd.Awarded supplierGB-COH: 00986738 Green Park, 250 Longwater Ave,, Reading, South East, RG2 6GB

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.